Results of the intravenous administration of tropisetron in fibromyalgia patients

Scandinavian Journal of Rheumatology, Supplement

Volumn 29, Issue 113, 2000, Pages 59-62

  Muller W ^a   Stratz, T ^a  

^a Hochrhein Institut   (Germany)

Author keywords

5 HT3 receptor antagonists; Fibromyalgia; Treatment; Tropisetron

Indexed keywords

SEROTONIN 3 ANTAGONIST; TROPISETRON; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST;

ADULT; AGED; ANALGESIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; MALE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT; SWEATING; TREATMENT OUTCOME; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADMINISTRATION, ORAL; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROMYALGIA; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; SEROTONIN ANTAGONISTS;

EID: 0033641480     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Varga B, Färber L, Kohnen R, Stratz Th, Wild J, Müller W. 4-wōchige Therapie mit dem 5-HT3-Rezeptor-Antagonisten Tropisetron-eine offene kontrollierte Pilotstudie. Act Rheumatol 2000;25:43-50.
2. Müller W, Lautenschläger J. Die generalisierte Tendomyopathie (GTM) Teil 1; Klinik Verlauf und Differentialdiagnose. Z Rheumatol 1990;49:11-21.
3. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
4. Färber L, Stratz Th, Müller W. Effectiveness of a 5-HT3-Receptor-Antagonist in Fibromyalgia. J Musculoskeletal Pain 1998;6 Suppl 2:150.